Research Topics
| George J ChangSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiationGeorge J Chang
Department of Surgical Oncology and Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Dis Colon Rectum 55:371-7. 2012..MR imaging permits precise delineation of tumor anatomy and assessment of mesorectal tumor penetration and radial margin risk...
Are we undertreating rectal cancer in the elderly? An epidemiologic studyGeorge J Chang
Department of Surgical Oncology, University of Texas, M D Anderson, Cancer Center, Houston, TX 77030, USA
Ann Surg 246:215-21. 2007..To better understand the reasons for decreased survival rates in elderly patients with rectal cancer by performing an epidemiologic evaluation of age-related differences in treatment and survival...
A twenty-year experience with adenocarcinoma of the anal canalGeorge J Chang
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Dis Colon Rectum 52:1375-80. 2009..Adenocarcinoma of the anal canal is a rare malignancy with limited data regarding treatment and outcomes. The purpose of this study is to evaluate disease control and survival outcomes in patients with adenocarcinoma of the anal canal...
Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcomeGeorge J Chang
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
Cancer 115:5432-40. 2009..The purpose of this study was to perform a population-based evaluation of the impact of pathologic LN status (ypN) after neoadjuvant radiotherapy on survival...
Lymph node evaluation and survival after curative resection of colon cancer: systematic reviewGeorge J Chang
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1400 Holcombe Blvd, Unit 444, Houston, TX 77030, USA
J Natl Cancer Inst 99:433-41. 2007..We performed a systematic review of the evidence for the association between lymph node evaluation and oncologic outcomes in patients with colon cancer...
Laparoscopic treatment of colorectal neoplasiaGeorge J Chang
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030 4009, USA
Curr Treat Options Gastroenterol 9:256-64. 2006..Despite these limitations, patient recovery benefits may offset the increased operative costs and result in improved outcome overall...
Practical application of a calculator for conditional survival in colon cancerGeorge J Chang
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1402, USA
J Clin Oncol 27:5938-43. 2009..In this study we performed a contemporary evaluation of conditional survival among colon cancer patients and created a browser-based tool for real-time determination of conditional survival expectancies...
Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiationPrajnan Das
Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Int J Radiat Oncol Biol Phys 77:60-5. 2010..To retrospectively determine rates of toxicity, freedom from local progression, and survival in rectal cancer patients treated with reirradiation...
Neoadjuvant treatment response as an early response indicator for patients with rectal cancerIn Ja Park
The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Clin Oncol 30:1770-6. 2012..The purpose of this study was to assess and compare oncologic outcomes associated with the degree of pathologic response after chemoradiotherapy...
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 76:824-30. 2010..We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based chemoradiation in locally advanced rectal cancer...
Predictors and patterns of recurrence after definitive chemoradiation for anal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 68:794-800. 2007..To evaluate patterns of locoregional failure, and predictors of recurrence and survival in patients treated with chemoradiation for anal cancer...
Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?Antoine Brouquet
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Am Coll Surg 210:934-41. 2010..An increasing number of patients with synchronous colorectal liver metastases (CLM) are candidates for resection. The optimal treatment sequence in these patients has not been defined...
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical courseMichael P Herman
Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 74:818-23. 2009..Our goal was to determine the incidence, risk factors, and clinical course of SI fractures in patients treated with preoperative chemoradiation for rectal cancer...
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse Kuan Yu
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 71:1175-80. 2008..To identify patterns of locoregional recurrence in patients treated with surgery and preoperative or postoperative radiotherapy or chemoradiation for rectal cancer...
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 109:1750-5. 2007..The objective of this study was to identify predictive factors for pathologic complete response and tumor downstaging after preoperative chemoradiation for rectal cancer...
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data BaseJohn R Hyngstrom
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:2814-21. 2012..We evaluated clinical features and survival outcomes among patients with signet ring and mucinous histologies of colorectal adenocarcinoma by using data from the National Cancer Data Base (NCDB)...
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapyScott Kopetz
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
J Clin Oncol 27:3677-83. 2009....
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinomaChiaojung Jillian Tsai
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:3713-22. 2011....
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysisPrajnan Das
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 66:1378-83. 2006....
Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinomaChristopher J Gannon
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 14:1870-7. 2007..To assist in patient selection for radical surgery, we sought to determine clinicopathologic factors influencing recurrence and disease-free survival (DFS) of LARC...
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive diseaseTawnya L Bowles
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:2015-23. 2010..Conditional survival estimates provide useful prognostic information for cancer survivors. The objective of this study was to determine conditional survival estimates for melanoma patients with substages of stage III disease...
Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapyIn Ja Park
Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77230 1402, USA
Dis Colon Rectum 56:135-41. 2013..Therefore, tumor response in the bowel wall has been proposed to be used to identify patients for organ-preserving strategies...
Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastasesSusan B Kesmodel
Department of Surgical Oncology, Cancer Biology, Biostatistics, and Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 26:5254-60. 2008..We therefore evaluated whether neoadjuvant BV is associated with an increase in postoperative complications in patients undergoing surgery for CRC liver metastases...
Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtypeCary Hsu
Department of Surgical Oncology and Cancer Surgical Outcomes Group, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030 1402, USA
J Surg Oncol 107:136-43. 2013..Neuroendocrine tumors (NETs) of the appendix include malignant carcinoid tumor (MCT), goblet cell carcinoid (GCT), and composite goblet cell carcinoid-adenocarcinoma (CGCC-A)...
Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastasesDaniel E Abbott
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Am Coll Surg 215:262-70. 2012..However, the safety and efficacy of simultaneous resection have been demonstrated in selected patients. The purpose of this study was to evaluate outcomes and economic implications of simultaneous and staged resections...
Multimodality salvage of recurrent disease after local excision for rectal cancerY Nancy You
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230 4008, USA
Dis Colon Rectum 55:1213-9. 2012..Local excision, alone or in combination with chemoradiation, is increasingly considered for rectal cancer. Higher risks of disease recurrence have been demonstrated after local excision...
A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare diseaseMichael J Overman
Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 19:1439-45. 2012..Because of its rarity, adenocarcinoma of the small intestine is frequently compared to adenocarcinoma of the colon, although the validity of this comparison is not known...
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancerPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Clin Oncol 29:219-24. 2006..To identify predictive factors for locoregional recurrence (LR), distant metastasis (DM), and overall survival (OS) in patients treated with chemoradiation and surgery for rectal cancer...
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancerSunil Krishnan
Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 66:762-71. 2006..The pathologic response rate is comparable to our previous experience using protracted venous infusion 5-FU for LARC...
Prognostic value of quality of life and pain in patients with locally recurrent rectal cancerY Nancy You
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 18:989-96. 2011..While curative resection offers survival benefits, significant trade-offs exist for the patient. Knowledge of patient-reported outcomes will help inform treatment decisions...
Capecitabine and timing of radiotherapy during preoperative chemoradiation for rectal cancerManpreet Bedi
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX
Gastrointest Cancer Res 1:44-8. 2007..We retrospectively investigated whether the timing of radiotherapy affects rates of acute toxicity, pathologic response, and relapse in rectal cancer patients receiving capecitabine...
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysisChing Wei D Tzeng
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 20:482-90. 2013..We sought to evaluate the surgical morbidity of proctectomy for colorectal cancer after previous liver surgery...
MR imaging for preoperative evaluation of primary rectal cancer: practical considerationsHarmeet Kaur
Department of Diagnostic Radiology, University of Texas M D Anderson Cancer Center, 1400 Pressler St, Unit 1473, Houston, TX 77030, USA
Radiographics 32:389-409. 2012..Three-dimensional T2-weighted imaging provides multiplanar capability with a superior signal-to-noise ratio compared with two-dimensional T2-weighted imaging...
Reverse-hybrid robotic mesorectal excision for rectal cancerIn Ja Park
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TC 77230, USA
Dis Colon Rectum 55:228-33. 2012....
Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiationKerrington D Smith
Department of Surgical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 251:261-4. 2010..The objective of this study was to determine the prevalence and prognostic significance of acellular mucin within resected specimens of rectal cancer patients with a pCR following preoperative chemoradiation...
Long-term survival and recurrence outcomes following surgery for distal rectal cancerEric J Silberfein
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:2863-9. 2010..The purpose of this study is to evaluate operative and pathologic factors associated with long-term survival and local recurrence outcomes in patients treated for distal rectal cancer...
Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results databaseMichael J Overman
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 116:5374-82. 2010..The objective of the current study was to evaluate the impact of the number of positive and negative lymph nodes on survival after curative resection...
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canalJohn T Mullen
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 1402, USA
Ann Surg Oncol 14:478-83. 2007..For patients who present with persistent or locally recurrent disease, salvage abdominoperineal resection is the treatment of choice. The purpose of this study is to review our experience with salvage surgery in this group of patients...
Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancerGenevieve M Boland
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cancer 119:1593-601. 2013..The National Comprehensive Cancer Network (NCCN) has established working, expert consensus, and evidence-based guidelines for organ-specific cancer care, including care of patients with colon cancer...
Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systemsRyaz Chagpar
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 20:1170-8. 2013..With increasing interest in neuroendocrine tumors (NETs), three staging systems for NETs of the colon and rectum have been published. Their prognostic relevance has not been examined and compared in an independent clinical database...
Adherence to stage-specific treatment guidelines for patients with colon cancerRyaz Chagpar
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
J Clin Oncol 30:972-9. 2012..We sought to determine rates of and factors associated with adherence to the National Comprehensive Cancer Network (NCCN) treatment guidelines for colon cancer...
Sentinel lymph node evaluation does not improve staging accuracy in colon cancerSherry J Lim
Department of Surgical Oncology, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, P O Box 301402, Houston, Texas, 77230 1402, USA
Ann Surg Oncol 15:46-51. 2008..Here we evaluated the sensitivity, predictive value, and accuracy of SLN evaluation for determining lymph node status in resectable colon cancer...
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysisYan Xing
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 116:2234-41. 2010..The objective of this analysis was to provide melanoma-specific CS estimates to help clinicians promote more informed patient decision making...
Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancerMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA
Arch Surg 147:513-9. 2012..To calculate conditional survival estimates for patients with pancreatic adenocarcinoma...
Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resectionMiguel A Rodriguez-Bigas
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe, Houston, TX 77030, USA
Surg Oncol Clin N Am 19:847-59. 2010..The morbidity of these procedures is high and at times may compromise quality of life. Palliative surgical procedures can be considered; however, in some cases, palliative resections may not be better than nonsurgical palliation...
Management and outcomes of anorectal infection in the cancer patientBrian D Badgwell
Department of Surgical Oncology, Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Ann Surg Oncol 16:2752-8. 2009..In addition, we seek to identify factors which are associated with surgical intervention...
Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patientsIsabelle Bedrosian
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
J Natl Cancer Inst 102:401-9. 2010..Despite increased demand for contralateral prophylactic mastectomy (CPM), the survival benefit of this procedure remains uncertain...
An individualized conditional survival calculator for patients with rectal cancerTawnya L Bowles
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
Dis Colon Rectum 56:551-9. 2013..For rectal cancer, stage-related treatment (eg, neoadjuvant radiotherapy) affects pathologic stage and therefore stage-associated survival estimates...
Barriers to rehabilitation of colorectal cancer patientsMiguel A Rodriguez-Bigas
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
J Surg Oncol 95:400-8. 2007..Since 1993 there has been a decrease in colorectal cancer mortality. Thus, there are more cancer survivors. In this manuscript potential barriers encountered during the rehabilitation of the colorectal cancer patient will be discussed...
Midsacral amputation for en bloc resection of chordomaGanesh Rao
Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Neurosurgery 66:41-4. 2010..Resection of sacral tumors is difficult due to the proximity of neurovascular and visceral structures, and complete, or even partial, sacrectomy often results in functional loss for the patient...
Revisiting the effectiveness of interventions to decrease surgical site infections in colorectal surgery: A Bayesian perspectiveUma R Phatak
Department of Surgery, University of Texas Health Science Center at Houston, Houston, TX, USA
Surgery 152:202-11. 2012..To evaluate the evidence for interventions to decrease surgical site infections (SSIs) in colorectal operations using Bayesian meta-analysis...
Pneumoperitoneum in the cancer patientBrian Badgwell
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1400 Holcombe Boulevard, P O Box 301402, Houston, Texas 77030 1402, USA
Ann Surg Oncol 14:3141-7. 2007..The purpose of this study was to characterize clinical presentations and management strategy for pneumoperitoneum in cancer patients...
Extracolonic manifestations of hereditary colorectal cancer syndromesDaniel A Anaya
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas
Clin Colon Rectal Surg 21:263-72. 2008..The authors review the most common and clinically relevant extracolonic manifestations for each of these syndromes focusing on incidence, presentation, genotype/phenotype correlations, and management (including surveillance) strategies...
Surgical implications of colorectal cancer geneticsMiguel A Rodriguez-Bigas
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Unit 444, PO Box 301402, Houston, TX 77230 1402, USA
Surg Oncol Clin N Am 15:51-66, vi. 2006..This article discusses a practical approach for some of the issues likely to be encountered by the surgeon...
Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndromeKathleen M Schmeler
Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
Obstet Gynecol 115:432-4. 2010..We describe two cases of primary peritoneal cancer after BSO in women with Lynch syndrome or HNPCC...
Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective studyGeorge J Chang
Department of Surgery, University of California at San Francisco, San Francisco, California, USA
Dis Colon Rectum 45:453-8. 2002..The high persistence or recurrence rate in human immunodeficiency virus-positive patients suggests that multiple staged procedures and continued surveillance may be necessary...
Expanding the donor pool: can the Spanish model work in the United States?George J Chang
Department of Surgery, University of California, San Francisco, CA, USA
Am J Transplant 3:1259-63. 2003..The high Spanish organ donation rates are largely attributable to increased use of older donors. Utilizing similar proportions of older donors in the US would increase the donor pool by almost 40%...
Practice parameters for anal squamous neoplasmsPhillip R Fleshner
Fletcher Allen Health Care, 111 Colchester Avenue, Burlington, VT 05401, USA
Dis Colon Rectum 51:2-9. 2008
Laparoscopic colectomyGeorge J Chang
Division of Colon and Rectal Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Curr Gastroenterol Rep 7:396-403. 2005..Despite these limitations, patient recovery benefits may offset the increased operative costs and result in improved cost-effectiveness overall...
